08/13/2026 / By Willow Tohi

President Donald Trump signed an executive order Monday directing the U.S. Department of Health and Human Services to develop a comprehensive plan within 90 days for reshaping the nation’s childhood vaccination schedule, including separating combination vaccines, evaluating aluminum adjuvants and expanding parental choice.
The order represents the culmination of a 15-month legal battle initiated by California attorney Ray Flores, who sued HHS in May 2025 with funding from Children’s Health Defense. Flores alleged the federal government had failed for decades to comply with the National Childhood Vaccine Injury Act of 1986, which mandated the creation of a Task Force on Safer Childhood Vaccines and periodic reporting to Congress on vaccine-safety improvements.
HHS reinstated the task force in August 2025, shortly before its deadline to respond to Flores’ lawsuit. The agency has not acknowledged that the lawsuit prompted the restoration.
Congress enacted the National Childhood Vaccine Injury Act in 1986 to establish a compensation program for vaccine-injured individuals while limiting manufacturer liability. The law directed HHS to promote vaccines with “fewer and less serious adverse reactions” and required the secretary to maintain a task force composed of NIH, FDA and CDC leadership.
According to Flores’ complaint, HHS failed to submit required reports for decades. A task force established in 1990 was disbanded in 1998 and never reconstituted. The lawsuit noted that the CDC’s 1983 childhood immunization schedule included four vaccines, while the 2025 schedule included more than 75 doses across 19 vaccines.
Flores’ legal action drew on a 2018 lawsuit filed by then-private citizen Robert F. Kennedy Jr. against HHS, which sought copies of the vaccine-safety reports mandated by the 1986 law. HHS reportedly could not locate the reports.
The reinstated task force includes senior leadership from NIH, FDA and CDC, with NIH Director Jay Bhattacharya serving as chairman. This structure mirrors the statutory design from 1986, but medical experts question whether federal health officials can conduct truly independent reviews.
Dr. Jane M. Orient, executive director of the Association of American Physicians and Surgeons, said the panel does not resolve underlying conflicts of interest.
“The decision should be decided by parents on the advice of a physician dedicated to the welfare of each patient, with fully informed consent, not the dumbed-down, incomplete vaccine ‘information sheets,'” Orient said.
Dr. Michael Palmer of Doctors for COVID Ethics noted that achieving consensus among experts with differing views on vaccine risk-benefit ratios will prove challenging.
The executive order establishes “Gold Standard Childhood Vaccine Recommendations” that distinguish between universal immunizations, vaccines for high-risk populations, and those based on shared clinical decision-making. The order recommends that combination vaccines like MMR be administered as three separate single-disease shots once domestically available.
Karl Jablonowski, Ph.D., a scientist with Children’s Health Defense, cautioned that executive orders can be reversed by future administrations.
“If immunization policy remains politically dividing, the executive order is up for reelection on November 7, 2028,” Jablonowski said. “The remaining 819 days is not a lot of time to do the science.”
Flores called the task force’s reestablishment “the biggest victory in the Health Freedom Movement.”
The 90-day deadline places significant pressure on the task force to deliver actionable proposals to the White House. Key priorities include developing alternative adjuvants to aluminum, conducting comparative safety studies and improving vaccine safety monitoring and transparency.
The order also directs the Attorney General to pursue legal actions challenging state vaccine mandates that conflict with federal obligations regarding parental authority, religious freedom and disability accommodations.
Whether the task force functions as a scientific body focused on reducing adverse reactions or becomes a political vehicle for pharmaceutical interests remains an open question. The first major test will arrive with its proposals due within three months.
Sources for this article include:
Tagged Under:
big government, Donald Trump, health freedom, health science, lawsuit, progress, research, vaccine wars, vaccines, White House
This article may contain statements that reflect the opinion of the author